Unichem Laboratories Reports 79% Drop in Q4 Net Profit Amid Exceptional Costs
Unichem Laboratories Ltd, a prominent Indian pharmaceutical company, reported a sharp 79% decline in net profit for the fourth quarter ending March, primarily driven by significant exceptional items impacting its bottom line. Despite the substantial earnings contraction, investor sentiment remained resilient, with company shares closing at ₹372.50 on the BSE, marking a modest gain of…
